Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas
about
sameAs
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and woundsProstaglandin levels in seminal plasma and sperm extracts of the domestic turkey, and the effects of cyclooxygenase inhibitors on sperm mobilityCommon ground in the transcriptional profiles of wounds and tumorsThe critical role of Akt in cardiovascular functionPPARgamma mediates NSAIDs-induced upregulation of TFF2 expression in gastric epithelial cells5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological studyCOX inhibitors and breast cancerNon-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cellsStatin use and cancer risk: a comprehensive reviewNitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stressHelicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathwayRebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin.Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemopreventionAcquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo.Polyphenolic phytochemicals versus non-steroidal anti-inflammatory drugs: which are better cancer chemopreventive agents?Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancerReview article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells.Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells.Activation of β-catenin signaling is critical for doxorubicin-induced epithelial-mesenchymal transition in BGC-823 gastric cancer cell line.2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms.In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.Molecular basis of the potential of mesalazine to prevent colorectal cancer.Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs.Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm.Expression of C-Reactive Protein in Rectal Cancer.Chemopreventive efficacy of hesperetin (citrus flavonone) against 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
P2860
Q21146433-D9E534BA-8C1D-4754-940D-C2339B68D3BEQ24791548-353FB28F-E61B-479C-ADB8-59407411695AQ24804704-4E8DD94A-869D-4270-A8AC-90BD621D32B2Q28083829-63FA4319-6BBC-4239-8C59-94D66C927AC9Q28167099-EB40B407-5AF3-4D70-AFC9-9E706AAA291BQ28182523-A4B69D34-CDBE-4EAD-A2D9-0251DDDB28CEQ28194592-9ED3046F-36CD-4335-BB8C-CC7813F44BA5Q28210288-9B69FC0C-3657-459A-9AF4-DE185D586B8DQ34021312-3166BC48-7142-4751-B26F-5FED7A50AEAEQ34144679-1F3FB0F2-3741-4B9E-A856-FE147BB4160AQ35045577-BFD23724-5A36-4843-8024-0AF95DB446ADQ35680994-C6F20D80-315E-40E2-A242-281C3DE431C1Q35859243-C5AFAC9C-3EA6-44CB-95F4-427AAC1BD002Q35925121-3089D5B7-29BA-44CF-B4F5-C99C3E8D4C5DQ36028598-0B185D05-ACD4-4493-B1D0-CC369E828941Q36036860-B6505AD7-F3D9-462A-A5DB-553DF87FE4ADQ36041152-F1F42172-97ED-42CF-BD88-25F7B14449EFQ37098082-0C9776C6-ED7D-485D-B979-9AE8FFB0A51FQ37231752-D02796EA-BF5A-4603-8E56-6F25082D75A8Q37400742-B6623B91-8BD9-45FF-BBCE-DD40123AAD9FQ37646513-5470385F-807F-4DA3-9EF4-9CB290E7BCDCQ38444161-322EF3A0-7444-4457-BBCF-6DE48ACCB7D1Q38968034-D328F9A4-E7E4-42C9-A41B-7B56E7CB0C38Q39261852-27717197-FBB6-4346-A807-4C71CF77CE98Q39376007-A7E0C47A-B9F8-41AC-8F38-C680A4B812DDQ40262487-F168BB2F-6741-42AE-A91E-F9C7A04967EEQ40440440-96BD71D7-D373-4961-AEC9-03770551BD57Q40528401-85F324DF-71B9-40D4-B271-A96EAAD1E3CEQ43064986-C9C8183B-E5C6-460F-A4C4-DDF56CE01C36Q43266418-C0C7E857-CE74-451F-BB25-E17CA5BCA6A3Q46930696-6A74B1BC-287D-4CC1-AE95-7A77BD04F22AQ50233617-46E289A2-164E-4435-BBF6-B70E218EC20FQ54319665-57C8E2AE-C54D-4E92-9011-E086D3DF67AE
P2860
Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@ast
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@en
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@nl
type
label
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@ast
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@en
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@nl
prefLabel
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@ast
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@en
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@nl
P2093
P1433
P1476
Non-steroidal anti-inflammator ...... nesis of colorectal carcinomas
@en
P2093
J H Kleibeuker
J J Koornstra
P356
10.1016/S0140-6736(03)13915-3
P407
P577
2003-07-19T00:00:00Z